monoclonals (Cambridge Biotech)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemonoclonals (Cambridge Biotech)
Drug Alias NameMAbs (Cambridge Biotech)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsHerpes SimplexCytomegalovirus InfectionsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAquila Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHerpes SimplexCytomegalovirus InfectionsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A